Apollomics Inc (APLMW)
NASDAQ
The current APLMW market cap is 6.39M. The company's latest EPS is USD -0.4296 and P/E is -18.99.
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Revenue | ||
Operating Income | ||
Net Income |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 1.45M | 1.22M |
Operating Income | -233.6M | -53.62M |
Net Income | -240.81M | -172.6M |
Quarter End | ||
---|---|---|
USD ($) | USD ($) | |
Total Assets | ||
Total Liabilities | ||
Total Equity |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 76.48M | 55.39M |
Total Liabilities | 524.6M | 14.15M |
Total Equity | -448.12M | 41.23M |
Market Cap | 6.39M |
Price to Earnings Ratio | -18.99 |
Price to Sales Ratio | 2.72k |
Price to Cash Ratio | 102.26 |
Price to Book Ratio | 79.51 |
Dividend Yield | - |
Shares Outstanding | 401.8M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.02 (87.5%) |
Company Name | Apollomics Inc |
Address |
989 e. hillsdale blvd foster city, california 94404 |
Website | https://www.apollomicsinc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.